These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21160987)

  • 41. Radio-frequency ablation-based studies on VX2rabbit models for HCC treatment.
    Bimonte S; Leongito M; Piccirillo M; de Angelis C; Pivonello C; Granata V; Izzo F
    Infect Agent Cancer; 2016; 11():38. PubMed ID: 27525037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ablation of hepatocellular carcinoma.
    Kim YS; Lim HK; Rhim H; Lee MW
    Best Pract Res Clin Gastroenterol; 2014 Oct; 28(5):897-908. PubMed ID: 25260316
    [TBL] [Abstract][Full Text] [Related]  

  • 43. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiofrequency ablation versus surgical resection for the treatment of solitary hepatocellular carcinoma 2 cm or smaller: A cohort study in Taiwan.
    Wu CC; Tseng CW; Tseng KC; Chen YC; Wu TW; Chang SY; Chang YJ; Chao YC; Hsu CS
    J Formos Med Assoc; 2021 May; 120(5):1249-1258. PubMed ID: 33288401
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anatomic resection versus radiofrequency ablation with an ablative margin ≥ 1.0 cm for solitary small hepatocellular carcinoma measuring ≤ 3 cm: Comparison of long-term outcomes using propensity score matching analysis.
    Zhang C; Gao R; Guo S; Ning C; Li A; Wang X; Li S; Ding J; Kong X; Wang Q; Xu Y; Li J; Gao J; Wang S; Kong J; Ke S; Sun W
    Eur J Radiol; 2022 Oct; 155():110498. PubMed ID: 36049409
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk factors for the recurrence of early hepatocellular carcinoma treated by percutaneous radiofrequency ablation with a multiple-electrode switching system: a multicenter prospective study.
    Tan Y; Wang X; Ma K; Zhang L; Li J; Chen P; Zhang B
    Int J Hyperthermia; 2022; 39(1):190-199. PubMed ID: 35042449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma in Childs A cirrhotics-a retrospective study of 1,061 cases.
    Huang J; Hernandez-Alejandro R; Croome KP; Yan L; Wu H; Chen Z; Prasoon P; Zeng Y
    J Gastrointest Surg; 2011 Feb; 15(2):311-20. PubMed ID: 21052859
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma.
    Chan AC; Poon RT; Cheung TT; Chok KS; Chan SC; Fan ST; Lo CM
    World J Surg; 2012 Jan; 36(1):151-6. PubMed ID: 22030561
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of overall survival on surgical resection versus transarterial chemoembolization with or without radiofrequency ablation in intermediate stage hepatocellular carcinoma: a propensity score matching analysis.
    Lin CW; Chen YS; Lo GH; Hsu YC; Hsu CC; Wu TC; Yeh JH; Hsiao P; Hsieh PM; Lin HY; Shu CW; Hung CM
    BMC Gastroenterol; 2020 Apr; 20(1):99. PubMed ID: 32272898
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy and Safety of Combined Radiofrequency Ablation with Transarterial Chemoembolization in Patients with Barcelona Clinic Liver Cancer Stage A Hepatocellular Carcinoma Ineligible for Curative Treatment.
    Kim AR; Park E; Kwon SY; Park SJ; Kim YJ; Yoo BC; Choe WH; Kim JH; Hwang JH; Park SW; Kim YJ; Park HS; Yu MH; Jeon HJ
    Korean J Gastroenterol; 2019 Mar; 73(3):167-176. PubMed ID: 31013560
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Efficacy and Therapeutic Outcome of Bipolar Radiofrequency Ablation for the Treatment for Hepatocellular Carcinoma in the Real-World Setting, Compared with Monopolar Radiofrequency Ablation Conducted during the Same Period.
    Tanaka T; Takata K; Kunimoto H; Fukuda H; Yamauchi R; Tsuchiya N; Inomata S; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
    Oncology; 2020; 98(12):859-868. PubMed ID: 32799203
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies.
    Chen W; Lin X; Wu Z; Pan W; Ke Q; Chen Y
    Hepatol Int; 2024 Jun; 18(3):998-1010. PubMed ID: 38480604
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized trial comparing radiofrequency ablation and surgical resection for HCC conforming to the Milan criteria.
    Huang J; Yan L; Cheng Z; Wu H; Du L; Wang J; Xu Y; Zeng Y
    Ann Surg; 2010 Dec; 252(6):903-12. PubMed ID: 21107100
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Update on Percutaneous Local Ablative Procedures for the Treatment of Hepatocellular Carcinoma.
    Luerken L; Haimerl M; Doppler M; Uller W; Beyer LP; Stroszczynski C; Einspieler I
    Rofo; 2022 Oct; 194(10):1075-1086. PubMed ID: 35545102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Radiofrequency ablation as an alternative to hepatic resection for single small hepatocellular carcinomas.
    Kim GA; Shim JH; Kim MJ; Kim SY; Won HJ; Shin YM; Kim PN; Kim KH; Lee SG; Lee HC
    Br J Surg; 2016 Jan; 103(1):126-35. PubMed ID: 26572697
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Liver resection versus radiofrequency ablation in octogenarian patients for hepatocellular carcinoma: a propensity score multicenter analysis.
    Filippo R; Conticchio M; Ratti F; Inchingolo R; Gelli M; Anelli FM; Laurent A; Vitali GC; Magistri P; Assirati G; Felli E; Wakabayashi T; Pessaux P; Piardi T; Di Benedetto F; de'Angelis N; Briceno DFJ; Rampoldi AG; Adam R; Cherqui D; Aldrighetti L; Memeo R
    Surg Endosc; 2023 Apr; 37(4):3029-3036. PubMed ID: 36534162
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Long-term outcome of percutaneous radiofrequency ablation for periportal hepatocellular carcinoma: tumor recurrence or progression, survival and clinical significance.
    Cao S; Lyu T; Fan Z; Guan H; Song L; Tong X; Wang J; Zou Y
    Cancer Imaging; 2022 Jan; 22(1):2. PubMed ID: 34983650
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expressions of hypoxia-inducible factor-1 and epithelial cell adhesion molecule are linked with aggressive local recurrence of hepatocellular carcinoma after radiofrequency ablation therapy.
    Yamada S; Utsunomiya T; Morine Y; Imura S; Ikemoto T; Arakawa Y; Kanamoto M; Iwahashi S; Saito Y; Takasu C; Ishikawa D; Shimada M
    Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S436-42. PubMed ID: 24566861
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single Hepatocellular Carcinoma approached by curative-intent treatment: A propensity score analysis comparing radiofrequency ablation and liver resection.
    Di Sandro S; Benuzzi L; Lauterio A; Botta F; De Carlis R; Najjar M; Centonze L; Danieli M; Pezzoli I; Rampoldi A; Bagnardi V; De Carlis L
    Eur J Surg Oncol; 2019 Sep; 45(9):1691-1699. PubMed ID: 31072620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of clinical outcomes of radiofrequency ablation and surgical resection for hepatocellular carcinoma conforming to the Milan criteria: A systematic review and meta-analysis of recent randomized controlled trials.
    Jia Z; Zhang H; Li N
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1769-1777. PubMed ID: 33569810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.